Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Upadacitinib may effectively treat alopecia areata without side effects.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Certain medications can cause serious side effects, so it's important to report them.

A new compound shows promise as a topical treatment for hair loss.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

CS12192 effectively treats alopecia areata with better safety than current options.

A man developed skin issues from cancer medication, which improved with specific treatments.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.